Vext Science Yönetim

Eric Offenberger'un ücretlendirmesi Vext Science'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-US$7m
Mar 31 2024	n/a	n/a	-US$2m
Dec 31 2023	US$456k	US$306k	US$4m
Sep 30 2023	n/a	n/a	US$5m
Jun 30 2023	n/a	n/a	US$7m
Mar 31 2023	n/a	n/a	US$9m
Dec 31 2022	US$448k	US$360k	US$11m
Sep 30 2022	n/a	n/a	US$6m
Jun 30 2022	n/a	n/a	US$6m
Mar 31 2022	n/a	n/a	US$6m
Dec 31 2021	US$414k	US$300k	US$5m
Sep 30 2021	n/a	n/a	US$5m
Jun 30 2021	n/a	n/a	US$5m
Mar 31 2021	n/a	n/a	US$4m
Dec 31 2020	US$219k	US$219k	US$2m

Tazminat ve Piyasa: Eric 'nin toplam tazminatı ($USD 455.74K ), Canadian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 169.37K ).

Tazminat ve Kazançlar: Eric şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Eric Offenberger

5.9yrs

Görev süresi

US$455,739

Tazminat

Mr. Eric J. Offenberger has been the Chief Executive Officer and President of Vext Science, Inc. since February 18, 2020 and has been its Director since February 14, 2020 and serves as its Chief Operating...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Jason Nguyen	Founder & Executive Chairman	5.9yrs	US$555.00k	19.94% CA$ 9.6m
Eric Offenberger	CEO, COO	5.9yrs	US$455.74k	Veri yok
Trevor Smith	Chief Financial Officer	1.3yrs	US$65.39k	0.24% CA$ 113.7k
Nalee Pham	Company Secretary	1.3yrs	US$121.73k	0.041% CA$ 19.6k
Jonathan Ross	Investor Relations Officer	no data	Veri yok	Veri yok

1.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: VEXT 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Jason Nguyen	Founder & Executive Chairman	5.9yrs	US$555.00k	19.94% CA$ 9.6m
Eric Offenberger	CEO, COO	4.8yrs	US$455.74k	Veri yok
Mark Opzoomer	Independent Director	2.8yrs	US$84.75k	0.86% CA$ 412.7k
David Johns	Director	1.9yrs	US$46.15k	0.48% CA$ 230.4k
Scott Hill	Board Advisor	5.2yrs	Veri yok	Veri yok
Jeffery Yarger	Board Advisor	5.1yrs	Veri yok	Veri yok
Terry Creighton	Independent Director	less than a year	Veri yok	Veri yok
Spiro Phanos	Director	less than a year	Veri yok	0.073% CA$ 35.0k

3.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: VEXT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).

Vext Science Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Vext Science, Inc., Annual General Meeting, Dec 13, 2024

Chief Financial Officer recently bought CA$63k worth of stock

Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role

Vext Science, Inc., Annual General Meeting, Dec 15, 2023

Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023

Less than half of directors are independent

Recent updates

New minor risk - Share price stability

Vext Science, Inc. to Report Q3, 2024 Results on Nov 21, 2024

It's Down 26% But Vext Science, Inc. (CSE:VEXT) Could Be Riskier Than It Looks

Vext Science, Inc., Annual General Meeting, Dec 13, 2024

Price target decreased by 14% to CA$0.57

Second quarter 2024 earnings released: US$0.018 loss per share (vs US$0.004 profit in 2Q 2023)

Vext Science, Inc. to Report Q2, 2024 Results on Aug 20, 2024

Price target increased by 12% to CA$0.75

Take Care Before Jumping Onto Vext Science, Inc. (CSE:VEXT) Even Though It's 30% Cheaper

Chief Financial Officer recently bought CA$63k worth of stock

Vext Science, Inc. to Report Q1, 2024 Results on May 29, 2024

New minor risk - Earnings quality

Vext Science, Inc. to Report Q4, 2023 Results on Apr 25, 2024

New major risk - Shareholder dilution

Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role

There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vext Science, Inc. to Report Q3, 2023 Results on Nov 28, 2023

Vext Science, Inc., Annual General Meeting, Dec 15, 2023

New major risk - Shareholder dilution

Vext Science, Inc. announced that it has received $11.5 million in funding from LLF Financial S.A.

Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Second quarter 2023 earnings: EPS exceeds analyst expectations

Vext Science, Inc. to Report Q2, 2023 Results on Aug 23, 2023

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023

First quarter 2023 earnings released: EPS: US$0 (vs US$0.016 in 1Q 2022)

Vext Science, Inc. to Report Q1, 2023 Results on May 25, 2023

Price target increased by 7.2% to CA$1.30

Full year 2022 earnings released: EPS: US$0.079 (vs US$0.036 in FY 2021)

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Less than half of directors are independent

Vext Science, Inc. (CNSX:VEXT) entered into agreement to acquire Appalachian Pharm Processing, LLC for $12.5 million.

Vext Science, Inc. Announces Board Changes

Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

Price target decreased to CA$1.24

Third quarter 2022 earnings released: EPS: US$0.003 (vs US$0.007 in 3Q 2021)

Less than half of directors are independent

Vext Science, Inc. to Report Q3, 2022 Results on Nov 17, 2022

Price target decreased to CA$1.46

Vext Science, Inc., Annual General Meeting, Dec 15, 2022

We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Vext Science Announces Filing of Provisional Patent Application

Sopica Special Opportunities Fund Limited, managed by LLF Financial S.A. acquired a 13.65% stake in Vext Science, Inc. (CNSX:VEXT) from Jason T. Nguyen for $3 million.

Second quarter 2022 earnings released: EPS: US$0.014 (vs US$0.013 in 2Q 2021)

Director recently bought CA$53k worth of stock

Vext Science, Inc. to Report Q2, 2022 Results on Aug 24, 2022

Vext Science, Inc. Announces CFO Transition

First quarter 2022 earnings released

Vext Science, Inc. to Report Q1, 2022 Results on May 30, 2022

Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Price target decreased to CA$1.84

Less than half of directors are independent

Full year 2021 earnings released: EPS: US$0.036 (vs US$0.023 in FY 2020)

Vext Science, Inc. Announces Executive Changes

Vext Science, Inc. to Report Q4, 2021 Results on Apr 20, 2022

Price target decreased to CA$1.99

Less than half of directors are independent

Vext Science, Inc. Appoints Mark W. Opzoomer as Board of Director

Third quarter 2021 earnings released

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Second quarter 2021 earnings released

Is Vext Science (CSE:VEXT) A Risky Investment?

Vext Science, Inc. (CNSX:VEXT) completed the acquisition of a 72,000 square foot industrial facility in Eloy, Arizona.

First quarter 2021 earnings released

Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Full year 2020 earnings released

Vext Science, Inc. Announces CFO Changes

New 90-day high: CA$1.54